Skip to main content

FDA recall, , Moderate risk

Johnson & Johnson HEALON EndoCoat PRO and HEALON DUET PRO II

Viscoelastic products used in cataract procedures may cause corneal abrasion, iris trauma, or descemet's membrane detachment if forced.

What happened

Johnson & Johnson Surgical Vision, Inc., of Irvine, California, began a recall of HEALON EndoCoat PRO and HEALON DUET PRO II viscoelastic products on July 31, 2026, because surgical instructions state that forcing the cannula during insertion may cause corneal abrasion, iris trauma or descemet's membrane detachment. The FDA added the recall to its Enforcement Report on August 31, 2026, with nationwide distribution in the U.S. and worldwide.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is your can affected?

Affected if its UDI-DI and lot code are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Healon EndoCoat Pro, REF: 10300012 (US/CAN) Healon Duet Pro II, REF: 10300016 (US/CAN) Healon EndoCoat Pro, REF: 10301012 (EU); Healon Duet Pro II, REF: 10301016 (EU)

    UDI-DI
    • 10300012
    • 5050474755093
    • 10300016
    • 5050474755116
    • 10301012
    • 5050474755109
    • 10301016
    • 5050474755123
    Lot code
    • UA32232
    • UA32250
    • UA32268
    • UA32290
    • UA32292
    • UA32303
    • UA32371
    • UP31203
    • UP31205

Recall details

Company began the recall
Company
Johnson & Johnson Surgical Vision, Inc.Irvine, California
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99496
Recall number
Z-3064-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)